Radiotherapy Patient Positioning Devices Market
Number of pages: 100 | Report Format: PDF | Published date: April 10, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 565 million |
|
Revenue Forecast in 2031 |
US$ 907 million |
|
CAGR |
5.4% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product Type, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global radiotherapy patient positioning devices market was valued at US$ 565 million in 2022 and is expected to register a revenue CAGR of 5.4% to reach US$ 907 million by 2031.
Radiotherapy Patient Positioning Devices Market Fundamentals
Radiotherapy patient positioning devices are specialized equipment and tools that are used to ensure the accurate and reproducible positioning of a patient during radiation therapy. These devices are designed to hold the patient in a specific position to ensure that the radiation treatment is delivered precisely to the target area while minimizing the radiation dose to surrounding healthy tissues. These devices are essential in ensuring that the radiation treatment is delivered accurately and safely to the intended target while minimizing the risk of damage to healthy tissues. They also help to ensure that the radiation dose is consistent from one treatment session to the next, which is crucial for effective treatment outcomes.
[87788]
Radiotherapy Patient Positioning Devices Market Dynamics
The increasing incidence of cancer is a significant driver of the radiotherapy patient positioning devices market revenue growth. As the global cancer burden continues to rise, the demand for radiotherapy treatment will increase, thereby driving the demand for radiotherapy patient positioning devices. According to GLOBOCAN 2020 report, approximately 10 million deaths were cases by cancer in 2020. The development of advanced radiotherapy techniques such as image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) has increased the need for more precise and effective patient positioning devices. These devices play a critical role in ensuring the success of such advanced radiotherapy techniques. The demand for non-invasive treatment options is increasing due to their ability to minimize the side effects of radiation therapy. This drives the demand for radiotherapy patient positioning devices that can ensure accurate and effective radiation delivery while minimizing exposure to healthy tissues.
Additionally, healthcare providers increasingly focus on improving patient comfort and safety during radiotherapy treatments. As a result, the market revenue is expected to grow in demand for patient positioning accessories such as headrests, cushions, and other aids that ensure patient comfort and correct positioning. Governments and private healthcare providers are investing in healthcare infrastructure, including constructing new radiotherapy centers and adopting advanced radiotherapy technologies. This is expected to fuel the radiotherapy patient positioning devices market revenue growth during the forecast period. However, the regulatory requirements for the development and approval of radiotherapy patient positioning devices are strict, leading to delays in product launches and higher development costs, thus restricting the radiotherapy patient positioning device's market revenue growth. Furthermore, lacking skilled professionals in some regions hinders the demand for radiotherapy patient positioning devices.
The market revenue for radiotherapy patient positioning devices is driven by the increasing prevalence of cancer and the demand for more advanced radiation treatments. Additionally, technological advancements such as 3D printing, robotics, and AI are expected to create growth opportunities in the market during the forecast period. The market is also expected to grow due to the increasing adoption of image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) techniques.
Based on region, the radiotherapy patient positioning devices market revenue is dominated by North America, followed by Europe and Asia Pacific. This is due to factors such as the high incidence of cancer in North America, the presence of a large number of radiotherapy centers in Europe, and the increasing healthcare expenditure in the Asia Pacific region.
The key players in the radiotherapy patient positioning devices market include CIVCO Radiotherapy, Orfit Industries, Elekta AB, Bionix Llc, Qfix, and Varian Medical Systems. These companies are constantly innovating their products to improve patient comfort, treatment accuracy, and safety.
Radiotherapy Patient Positioning Devices Market Ecosystem
The global radiotherapy patient positioning devices market is analyzed from four perspectives: product type, end user, and region.
Radiotherapy Patient Positioning Devices Market by Product Type
[68890]
Based on the product type, the global radiotherapy patient positioning devices market is segmented into head, neck, and brain immobilization devices, thorax and breast immobilization devices, pelvic immobilization devices, and others.
The head, neck, and brain immobilization device segment accounts for the prominent revenue share in the radiotherapy patient positioning devices market. The high incidence of cancer in the head, neck, and brain regions is a key driver of demand for radiotherapy treatment in these areas. Due to the need for precise and accurate patient positioning for effective treatment delivery while minimizing the exposure of healthy tissues to radiation, specialized immobilization devices such as headrests, masks, and bite blocks have become necessary. Advancements in radiotherapy technology and techniques have made it possible to treat tumors in these areas more effectively, further increasing the demand for head, neck, and brain immobilization devices. Techniques such as stereotactic radiosurgery and stereotactic body radiation therapy require highly precise and accurate patient positioning, which can only be achieved using specialized immobilization devices. The head, neck, and brain regions contain critical organs and structures that require protection from radiation exposure during treatment. Immobilization devices play a vital role in ensuring the radiation is delivered to the target area while minimizing exposure to healthy tissues, thereby reducing the risk of side effects and complications.
The thorax and breast immobilization device segment is expected to grow at the fastest rate in terms of the revenue share of the global radiotherapy patient positioning devices market. Breast cancer is the most common cancer among women globally, and radiotherapy is a widely used treatment option for breast cancer. The use of immobilization devices such as breast boards is necessary for accurate treatment delivery and minimizing radiation exposure to healthy tissues. According to the WHO, there were 2.3 million women diagnosed with breast cancer in 2020 worldwide, and 685,000 deaths were caused due to breast cancer. The growing awareness among patients and healthcare professionals about the importance of minimizing radiation exposure to healthy tissues during radiotherapy treatment drives the demand for high-quality immobilization devices that provide optimal patient positioning and reduce radiation exposure. Developing new materials and technologies for immobilization devices is expected to boost the revenue growth of the thorax and breast immobilization device segment. Furthermore, advancements in radiotherapy technology and techniques have led to increased use of intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) for treating thorax and breast cancers. These advanced techniques require specialized immobilization devices to ensure precise and accurate patient positioning for effective treatment delivery.
Radiotherapy Patient Positioning Devices Market by End User
Based on end users, the global radiotherapy patient positioning devices market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others.
The hospital's segment accounted for a significant revenue share of the radiotherapy patient positioning devices market. Hospitals are the primary providers of cancer care and radiotherapy treatment. They typically have well-established radiotherapy departments equipped with advanced radiotherapy technologies and devices. The high patient volume in hospitals requires efficient patient management systems, including high-quality patient positioning devices, to ensure optimal treatment delivery. Hospitals have large budgets and resources to invest in advanced radiotherapy technologies and devices, including patient positioning devices. This allows them to provide the best possible care for cancer patients and maintain a competitive edge in the market. Hospitals often collaborate with research institutions and manufacturers to develop new, advanced patient positioning devices that meet their needs and requirements. These partnerships enable hospitals to stay at the forefront of the latest technological advancements in the field and maintain a strong position in the market. The increasing focus on patient-centric care and the need to provide personalized treatment options drive the demand for advanced patient positioning products that provide accurate and precise treatment delivery. Hospitals are well-positioned to meet these demands due to their resources, expertise, and access to advanced technologies, boosting the segment's revenue growth.
The specialty clinics segment is expected to experience a lucrative revenue CAGR in the global radiotherapy patient positioning devices market. Specialty clinics cater to patients with specific medical conditions, such as cancer, and offer personalized care with advanced technologies. Although they have smaller patient volumes than hospitals, they require high-quality patient positioning devices for precise and accurate treatment delivery. With the rising prevalence of cancer and demand for specialized cancer care, specialty clinics are becoming a preferred choice for patients due to their personalized approach and shorter wait times. They adopt advanced technologies such as image-guided radiotherapy and require specialized patient positioning devices that support these technologies. The growing focus on patient-centric care and personalized treatment options drives the demand for advanced positioning devices, which specialty clinics are well-equipped to provide due to their expertise and emphasis on individualized patient care.
Radiotherapy Patient Positioning Devices Market by Region
Geographically, the global radiotherapy patient positioning devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America has the highest radiotherapy patient positioning devices market revenue. The rising incidence of cancer in North America drives the demand for radiotherapy treatment and patient positioning devices. According to the American Cancer Society, an estimated 1.9 million new cancer cases were diagnosed in the U.S., and it caused 609,360 deaths in 2022. The region has a high level of healthcare expenditure, which allows for greater investment in advanced medical technologies, including patient positioning devices. North America has a well-established healthcare infrastructure with many radiotherapy centers that use advanced technologies, creating a favorable environment for adopting patient positioning devices. The region's strong presence of key market players and research institutions contributes to developing innovative patient positioning devices and technology. The regulatory environment in North America supports the development and commercialization of advanced medical devices, further promoting revenue growth in the global radiotherapy patient positioning devices market.
Radiotherapy Patient Positioning Devices Market Competitive Landscape
The prominent players operating in the global radiotherapy patient positioning devices market are:
Radiotherapy Patient Positioning Devices Market Strategic Developments
The expected size of the global radiotherapy patient positioning devices market in 2031 is US$ 907 million.
During the forecast period, the revenue CAGR of the global radiotherapy patient positioning devices market is expected to be 5.4%.
The prominent players operating in the global radiotherapy patient positioning devices market are CIVCO Radiotherapy, Orfit Industries NV, Elekta AB, Bionix LLC, Qfix, and Varian Medical Systems.
North America has the largest market revenue share in terms of revenue. Asia Pacific has the fastest revenue growth rate, which can be considered the key growth region due to the rapid market revenue growth.
The lack of skilled professionals and stringent regulatory requirements are some of the restricting factors of the market revenue.
*Insights on financial performance are subject to the availability of information in the public domain